Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity

Royce Ma, Mae Woods, Phillip Burkhardt, Noah Crooks, Dayenne G. van Leeuwen, Daniil Shmidt, Jacob Couturier, Alexandre Chaumette, Divya Popat, La Quisa C. Hill, Rayne H. Rouce, Sachin Thakkar, Aaron F. Orozco, Alexandre F. Carisey, Malcolm K. Brenner, Maksim Mamonkin

Research output: Contribution to journalArticlepeer-review

Abstract

Chimeric antigen receptor T cells (CART) targeting lymphocyte antigens can induce T cell fratricide and require additional engineering to mitigate self-damage. We demonstrate that the expression of a chimeric antigen receptor (CAR) targeting CD5, a prominent pan-T cell antigen, induces rapid internalization and complete loss of the CD5 protein on T cells, protecting them from self-targeting. Notably, exposure of healthy and malignant T cells to CD5.CART cells induces similar internalization of CD5 on target cells, transiently shielding them from cytotoxicity. However, this protection is short-lived, as sustained activity of CD5.CART cells in patients with T cell malignancies results in full ablation of CD5+ T cells while sparing healthy T cells naturally lacking CD5. These results indicate that continuous downmodulation of the target antigen in CD5.CART cells produces effective fratricide resistance without undermining their on-target cytotoxicity.

Original languageEnglish (US)
Article number101628
JournalCell Reports Medicine
Volume5
Issue number7
DOIs
StatePublished - Jul 16 2024

Keywords

  • CAR
  • CD5
  • chimeric antigen receptor
  • clinical trials
  • fratricide
  • off-tumor toxicity
  • T cell fratricide
  • T cell malignancies

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this